Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Dose-Ranging Study of SYR-472 in Type 2 Diabetes Mellitus
jRCT2080220868Phase 2
- Sponsor
- Takeda
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of trelagliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
trelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220868.